Inovio Pharmaceuticals, Inc. (INO) by event type

INO moves most on price-target cuts — a median of -0.43% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the INO overview →

By event type

How INO reacts across 5 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
520 of 2,717
13+0.36%69%+0.45%
Analyst downgrades
2,137 of 2,603
11-0.41%36%0.00%
Coverage initiations
1,104 of 2,283
220.00%41%-0.09%
Rating reiterations
2,728 of 3,522
34-0.13%44%-0.63%
Price-target cuts
1,433 of 1,527
10-0.43%10%-0.86%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.

That’s how INO usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · INO overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
OPHTHOTECH CORP COMMON (OPHT)660-0.20%43%
Gritstone bio, Inc. (GRTS)659-0.01%50%
VistaGen Therapeutics, Inc. (VTGN)658+0.16%52%
Quanterix Corporation (QTRX)657-0.21%46%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.